AN2 Therapeutics Inc (ANTX)

1.42 +0.03 (+2.16%) USD  |  NASDAQ  |  Jan 03, 16:00
1.43 +0.01 (+0.70%) After-Hours: 20:00
More

AN2 Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp Upgrade
GlycoMimetics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade